[1]
“CAR-T-ICI: COMBINATION OF CHIMERIC ANTIGEN RECEPTOR T-CELL WITH ANTI PD-1 IMMUNE CHECKPOINT INHIBITOR AS A NOVEL TREATMENT FOR COLORECTAL CANCER: Combination of chimeric antigen receptor T-cell with anti PD-1 immune checkpoint inhibitor as a novel treatment for colorectal cancer”, JIMKI, vol. 9, no. 1, pp. 56–68, Jul. 2021, doi: 10.53366/jimki.v9i1.339.